1
|
Estravís M, Pérez-Pazos J, Moreno-Jimenez E, Triviño JC, García-Sánchez A, Gómez-García M, Morgado N, Ramos-González J, Gil-Melcón M, Martín-García C, Muñoz-Bellido F, Sanz C, Isidoro-García M, Dávila I. Transcriptomics reveals new regulatory mechanisms involved in benralizumab response. Allergy 2023; 78:3023-3026. [PMID: 37641395 DOI: 10.1111/all.15869] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2023] [Revised: 07/27/2023] [Accepted: 08/12/2023] [Indexed: 08/31/2023]
Affiliation(s)
- Miguel Estravís
- Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain
- Red de Enfermedades Inflamatorias - Instituto de Salud Carlos III, Madrid, Spain
| | - Jacqueline Pérez-Pazos
- Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain
- Clinical Biochemistry Department Salamanca, Pharmacogenetics and Precision Medicine Unit, Hospital Universitario de Salamanca, Salamanca, Spain
| | - Emma Moreno-Jimenez
- Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain
- Microbiology and Genetics Department Salamanca, Universidad de Salamanca, Salamanca, Spain
| | | | - Asunción García-Sánchez
- Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain
- Red de Enfermedades Inflamatorias - Instituto de Salud Carlos III, Madrid, Spain
- Biomedical and Diagnostics Sciences Department, Universidad de Salamanca, Salamanca, Spain
| | - Manuel Gómez-García
- Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain
- Clinical Biochemistry Department Salamanca, Pharmacogenetics and Precision Medicine Unit, Hospital Universitario de Salamanca, Salamanca, Spain
| | - Natalia Morgado
- Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain
- Biomedical and Diagnostics Sciences Department, Universidad de Salamanca, Salamanca, Spain
| | | | - María Gil-Melcón
- Otorhinolaryngology and Head and Neck Surgery Department, Hospital Universitario de Salamanca, Salamanca, Spain
| | - Cristina Martín-García
- Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain
- Allergy Department, Hospital Universitario de Salamanca, Salamanca, Spain
| | - Francisco Muñoz-Bellido
- Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain
- Red de Enfermedades Inflamatorias - Instituto de Salud Carlos III, Madrid, Spain
- Allergy Department, Hospital Universitario de Salamanca, Salamanca, Spain
| | - Catalina Sanz
- Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain
- Red de Enfermedades Inflamatorias - Instituto de Salud Carlos III, Madrid, Spain
- Microbiology and Genetics Department Salamanca, Universidad de Salamanca, Salamanca, Spain
| | - María Isidoro-García
- Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain
- Red de Enfermedades Inflamatorias - Instituto de Salud Carlos III, Madrid, Spain
- Medicine Department, Universidad de Salamanca, Salamanca, Spain
- Clinical Biochemistry Department, Hospital Universitario de Salamanca, Salamanca, Spain
| | - Ignacio Dávila
- Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain
- Red de Enfermedades Inflamatorias - Instituto de Salud Carlos III, Madrid, Spain
- Synlab Group, Sistemas Genómicos SL, Valencia, Spain
- Allergy Department, Hospital Universitario de Salamanca, Salamanca, Spain
| |
Collapse
|
2
|
Estravís M, Pérez-Pazos J, Martin MJ, Ramos-González J, Gil-Melcón M, Martín-García C, García-Sánchez A, Sanz C, Dávila I. Correspondence regarding the paper "Laorden D, Zamarrón E, Romero D, Domínguez-Ortega J, Villamañán E, Losantos I, Gayá F, Quirce S, Álvarez-Sala R. Evaluation of FEOS score and super-responder criteria in a real-life cohort treated with anti-IL5/IL5R. Respir. Med. 2023; 211: 107216". Respir Med 2023; 214:107280. [PMID: 37172788 DOI: 10.1016/j.rmed.2023.107280] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/28/2023] [Accepted: 05/09/2023] [Indexed: 05/15/2023]
Affiliation(s)
- Miguel Estravís
- Grupo de Investigación en Alergia, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain; Red de Investigación Cooperativa Orientada a Resultados en Salud-RICORS, ISCIII, Salamanca, Spain
| | - Jacqueline Pérez-Pazos
- Grupo de Investigación en Alergia, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain; Unidad de Farmacogenética y Medicina de Precisión, Servicio de Bioquímica Clínica, Servicio de Alergología, Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain
| | - Maria J Martin
- Grupo de Investigación en Alergia, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain; Red de Investigación Cooperativa Orientada a Resultados en Salud-RICORS, ISCIII, Salamanca, Spain; Departamento de Bioquímica y Biología Molecular, Universidad de Salamanca, Salamanca, Spain
| | - Jacinto Ramos-González
- Servicio de Neumología, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain
| | - María Gil-Melcón
- Servicio de Otorrinolaringología, Complejo Asistencial Univesitario de Salamanca, Salamanca, Spain
| | - Cristina Martín-García
- Grupo de Investigación en Alergia, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain; Servicio de Inmunoalergia, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain
| | - Asunción García-Sánchez
- Grupo de Investigación en Alergia, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain; Red de Investigación Cooperativa Orientada a Resultados en Salud-RICORS, ISCIII, Salamanca, Spain; Departamento de Ciencias Biomédicas y del Diagnóstico, Universidad de Salamanca, Salamanca, Spain.
| | - Catalina Sanz
- Grupo de Investigación en Alergia, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain; Red de Investigación Cooperativa Orientada a Resultados en Salud-RICORS, ISCIII, Salamanca, Spain; Departamento de Microbiología y Genética, Universidad de Salamanca, Salamanca, Spain
| | - Ignacio Dávila
- Grupo de Investigación en Alergia, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain; Red de Investigación Cooperativa Orientada a Resultados en Salud-RICORS, ISCIII, Salamanca, Spain; Servicio de Inmunoalergia, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain; Departamento de Ciencias Biomédicas y del Diagnóstico, Universidad de Salamanca, Salamanca, Spain
| |
Collapse
|
3
|
Estravís M, Pérez-Pazos J, Martin MJ, Ramos-González J, Gil-Melcón M, Martín-García C, García-Sánchez A, Sanz C, Dávila I. Quantitative and qualitative methods of evaluating response to biologics in severe asthma patients: Results from a real-world study. J Allergy Clin Immunol Pract 2023; 11:949-951.e2. [PMID: 36423868 DOI: 10.1016/j.jaip.2022.11.009] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/30/2022] [Revised: 10/24/2022] [Accepted: 11/04/2022] [Indexed: 11/23/2022]
Affiliation(s)
- Miguel Estravís
- Grupo de investigación en Alergia, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain; Red de Investigación Cooperativa Orientada a Resultados en Salud-RICORS, ISCIII, Salamanca, Spain; Red Cooperativa de Investigación en Salud-RETICS ARADyAL, ISCIII, Madrid, Spain
| | - Jacqueline Pérez-Pazos
- Grupo de investigación en Alergia, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain; Unidad de Farmacogenética y Medicina de Precisión, Servicio de Bioquímica Clínica, Servicio de Alergología, Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain
| | - Maria J Martin
- Grupo de investigación en Alergia, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain; Red de Investigación Cooperativa Orientada a Resultados en Salud-RICORS, ISCIII, Salamanca, Spain; Red Cooperativa de Investigación en Salud-RETICS ARADyAL, ISCIII, Madrid, Spain; Departamento de Bioquímica y Biología Molecular, Universidad de Salamanca, Salamanca, Spain
| | - Jacinto Ramos-González
- Servicio de Neumología, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain
| | - María Gil-Melcón
- Servicio de Otorrinolaringología, Complejo Asistencial Univesitario de Salamanca, Salamanca, Spain
| | - Cristina Martín-García
- Servicio de Inmunoalergia, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain
| | - Asunción García-Sánchez
- Grupo de investigación en Alergia, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain; Red de Investigación Cooperativa Orientada a Resultados en Salud-RICORS, ISCIII, Salamanca, Spain; Red Cooperativa de Investigación en Salud-RETICS ARADyAL, ISCIII, Madrid, Spain; Departamento de Ciencias Biomédicas y del Diagnóstico, Universidad de Salamanca, Salamanca, Spain.
| | - Catalina Sanz
- Grupo de investigación en Alergia, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain; Red de Investigación Cooperativa Orientada a Resultados en Salud-RICORS, ISCIII, Salamanca, Spain; Red Cooperativa de Investigación en Salud-RETICS ARADyAL, ISCIII, Madrid, Spain; Departamento de Microbiología y Genética, Universidad de Salamanca, Salamanca, Spain
| | - Ignacio Dávila
- Grupo de investigación en Alergia, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain; Red de Investigación Cooperativa Orientada a Resultados en Salud-RICORS, ISCIII, Salamanca, Spain; Red Cooperativa de Investigación en Salud-RETICS ARADyAL, ISCIII, Madrid, Spain; Servicio de Inmunoalergia, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain; Departamento de Ciencias Biomédicas y del Diagnóstico, Universidad de Salamanca, Salamanca, Spain
| |
Collapse
|
4
|
Martin MJ, Garcia-Sanchez A, Estravis M, Gil-Melcón M, Isidoro-Garcia M, Sanz C, Davila I. Genetics and Epigenetics of Nasal Polyposis: A Systematic Review. J Investig Allergol Clin Immunol 2021; 31:196-211. [PMID: 33502318 DOI: 10.18176/jiaci.0673] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Chronic rhinosinusitis (CRS) is an inflammatory disease of the nose and paranasal sinuses that is often associated with nasal polyposis (CRSwNP) in the most severe cases. As in other complex diseases, genetic factors are thought to play an important role in the risk and development of the disease. Environment may also modulate the epigenetic signature in affected patients. In the present systematic review, we aimed to compile all published data on genetic and epigenetic variations in CRSwNP since 2000. We found 104 articles, 24 of which were related to epigenetic studies. We identified more than 150 genetic variants in 99 genes involved in the pathogenesis of nasal polyposis. These were clustered into 8 main networks, linking genes involved in inflammation and immune response (eg, MHC), cytokine genes (eg, TNF), leukotriene metabolism, and the extracellular matrix. A total of 89 miRNAs were also identified; these are associated mainly with biological functions such as the cell cycle, inflammation, and the immune response. We propose a potential relationship between genes and the miRNAs identified that may open new lines of investigation. An in-depth knowledge of gene variants and epigenetic traits could help us to design more tailored treatment for patients with CRSwNP.
Collapse
Affiliation(s)
- M J Martin
- IBSAL, Institute of Biomedical Research of Salamanca, Salamanca, Spain.,Network for Cooperative Research in Health-RETICS ARADyAL, Salamanca, Spain.,Department of Biochemistry and Molecular Biology, University of Salamanca, Salamanca, Spain
| | - A Garcia-Sanchez
- IBSAL, Institute of Biomedical Research of Salamanca, Salamanca, Spain.,Network for Cooperative Research in Health-RETICS ARADyAL, Salamanca, Spain.,Department of Biomedical and Diagnostics Sciences, University of Salamanca, Salamanca, Spain
| | - M Estravis
- IBSAL, Institute of Biomedical Research of Salamanca, Salamanca, Spain.,Network for Cooperative Research in Health-RETICS ARADyAL, Salamanca, Spain.,Department of Biomedical and Diagnostics Sciences, University of Salamanca, Salamanca, Spain
| | - M Gil-Melcón
- Department of Otorhinolaryngology/Servicio de Otorrinolaringología, Hospital Universitario de Salamanca, Salamanca, Spain
| | - M Isidoro-Garcia
- IBSAL, Institute of Biomedical Research of Salamanca, Salamanca, Spain.,Network for Cooperative Research in Health-RETICS ARADyAL, Salamanca, Spain.,Department of Clinical Biochemistry/Servicio de Bioquímica Clínica, Hospital Universitario de Salamanca, Salamanca, Spain.,Department of Medicine, University of Salamanca, Salamanca, Spain
| | - C Sanz
- IBSAL, Institute of Biomedical Research of Salamanca, Salamanca, Spain.,Network for Cooperative Research in Health-RETICS ARADyAL, Salamanca, Spain.,Department of Microbiology and Genetics, University of Salamanca, Salamanca, Spain
| | - I Davila
- IBSAL, Institute of Biomedical Research of Salamanca, Salamanca, Spain.,Network for Cooperative Research in Health-RETICS ARADyAL, Salamanca, Spain.,Department of Biomedical and Diagnostics Sciences, University of Salamanca, Salamanca, Spain.,Department of Immunoallergy/Servicio de Inmunoalergia, Hospital Universitario de Salamanca, Salamanca, Spain
| |
Collapse
|
5
|
Mir-Bonafé JM, Fernández-López E, Cañueto J, Gil-Melcón M, García-Domínguez R, de Unamuno-Pérez P. Infliximab-related malignant melanoma and cranial nerves IX and XII palsy secondary to IFN-α2b therapy. Int J Dermatol 2013; 52:1613-5. [PMID: 23432398 DOI: 10.1111/j.1365-4632.2011.05452.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Affiliation(s)
- José M Mir-Bonafé
- From the Departments of Dermatology, Otolaryngology, and Oncology, University Hospital of Salamanca, Paseo de San Vicente, Salamanca, Spain
| | | | | | | | | | | |
Collapse
|
6
|
Beltrán-Mateos LD, Cruz-Ruiz SS, Coscarón-Bernabé E, Solana-Sorribas J, Gil-Melcón M, Batuecas-Caletrí Á. Inseguridad fóbica ortostática. Acta Otorrinolaringológica Española 2007. [DOI: 10.1016/s0001-6519(07)74955-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
7
|
Beltrán-Mateos LD, Santa Cruz-Ruiz S, Coscarón-Bernabé E, Solana-Sorribas J, Gil-Melcón M, Batuecas-Caletrío A. [Phobic orthostatic insecurity]. Acta Otorrinolaringol Esp 2007; 58:393-400. [PMID: 17999903] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Abstract
BACKGROUND AND OBJECTIVES The authors attempt to expand knowledge about a subjective balance disorder they have called phobic orthostatic insecurity, a condition representing the second cause of medical visits (22.3 %) to their ENT and neuro-otology clinic, and attempt to identify relationships with similar conditions described in psychiatry (agoraphobia, somatoform vertigo, and space-phobia) and in neurology (phobic postural vertigo). They also propose a simple diagnostic method and present their therapies and results. PATIENTS AND METHOD A total of 151 patients with an indefinite symptomatology of "dizziness" "vertigo" or "insecurity" were evaluated (from 1999 to 2005) by means of a full medical history and an appropriate neurological examination, pharmacological treatments with anxiolytics-antidepressives, a measurement of the degree of depression with the Beck test (a kind of psychiatric benchmark) and with a specific standardized test. RESULTS Three symptoms and one exploratory condition, among others, were found in all 151 patients studied; these constitute the four bases for a positive diagnosis. This is confirmed if the treatment achieves total remission (this occurred in 69.53 % of all patients) or a sub-total remission (24.49 %), according to valuation scale for insecurity in all situations. CONCLUSIONS The statistical analysis showed a symptomatic concordance within the group analyzed, a syndromic equivalence between patients and satisfactory results with the antidepressive treatments (94 %), thus confirming the diagnostic and aetiopathogenic hypotheses for the disorder and, later, providing a logical method for diagnosis. The authors propose to assimilate this diagnostic protocol (and therapeutic when no specialist psychotherapy teams are available) to most of the psychogenic insecurity syndromes described.
Collapse
Affiliation(s)
- Luis D Beltrán-Mateos
- Servicio de Otorrinolaringología, Hospital Virgen de la Concha, Zamora [corrected] España.
| | | | | | | | | | | |
Collapse
|
8
|
Beltrán-Mateos LD, Cruz-Ruiz SS, Coscarón-Bernabé E, Solana-Sorribas J, Gil-Melcón M, Batuecas-Caletrío Á. Phobic Orthostatic Insecurity. Acta Otorrinolaringologica (English Edition) 2007. [DOI: 10.1016/s2173-5735(07)70377-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|